COR Cencora, Inc.
Healthcare$270.78-1.50%ClosedMarket Cap: $52.68B
As of 2026-05-26
Valuation
P/E (TTM)
38.40
PEG
2.34
P/B
15.74
P/S
0.16
EV/EBITDA
15.53
DCF Value
$630.21
FCF Yield
2.9%
Div Yield
0.9%
Margins & Returns
Gross Margin
3.5%
Operating Margin
1.3%
Net Margin
0.8%
ROE
115.9%
ROA
3.1%
ROIC
11.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $78.36B | 4.2% | $1.34B | $1.64B | $— | $0.60 |
| Q1 null | $85.93B | 3.3% | $1.02B | $559.6M | $— | $0.60 |
| Q4 null | $83.73B | 3.1% | $854.6M | $-339.7M | $— | $0.55 |
| FY null | $321.33B | 3.2% | $3.65B | $1.55B | $— | $2.20 |
| Q3 null | $80.66B | 3.3% | $985.5M | $687.4M | $— | $0.55 |
| Q2 null | $75.45B | 3.5% | $1.02B | $717.9M | $— | $0.55 |
| Q1 null | $81.49B | 2.8% | $791.8M | $488.6M | $— | $0.55 |
| Q4 null | $79.05B | 2.7% | $672.9M | $3.4M | $— | $0.51 |
| FY null | $293.96B | 3.0% | $3.04B | $1.51B | $— | $2.04 |
| Q3 null | $74.24B | 2.8% | $703.4M | $483.5M | $— | $0.51 |
| Q2 null | $68.41B | 3.3% | $868.8M | $420.8M | $— | $0.51 |
| Q1 2024 | $72.25B | 3.0% | $751.2M | $601.5M | $2.98 | $0.51 |